ImClone and Bristol-Myers Squibb Announce ERBITUX Study Results
ImClone Systems and Bristol-Myers Squibb announced the results of several clinical studies of ERBITUX, an IgG1 monoclonal antibody, presented at…
Part of the
network
network
Tag: monoclonal antibody
Phase III Avastin Study Results
Genentech and Roche announced that an interim analysis of a Phase III study of Avastin plus paclitaxel and carboplatin chemotherapies…
Shares of Elan and Biogen Idec Shares Rise
Shares of Elan and Biogen Idec went up following the companies' announcement of their multiple sclerosis drug Tysabri test results.
